Dexcom G6® CGM System Now Available In Canada
Revolutionary new Continuous Glucose Monitoring System eliminates fingersticks* for people with diabetes
"We are thrilled to offer the Dexcom G6 Continuous Glucose Monitoring (CGM) System to Canadians and are proud of this innovative technology that enables more effective diabetes management," said
The Dexcom G6 is now available and builds upon the core attributes of the Dexcom G5 Mobile CGM technology platform, while introducing new features that empower users to take control of their diabetes:
- Elimination of fingersticks for calibration and diabetes treatment decisions*
- Continuous glucose readings sent automatically using Bluetooth technology to any compatible smart device†, or to a
Dexcomreceiver, at five-minute intervals
- Customizable alerts and alarms, including a new Urgent Low Soon alert which can warn users up to 20 minutes in advance of an urgent hypoglycemic event, so they can take steps to prevent it
- Real-time data sharing with the Dexcom G6 app, allowing the user to share their glucose data with up to five followers to monitor their glucose levels remotely for extra peace of mind
- 10-day sensor allowing for longer wear (3 days longer than the previous generation Dexcom CGM)
- A slimmer transmitter with a lower profile for more discreet wear ability
- An auto-applicator designed to make sensor insertion simple with the touch of a button
- A newly designed receiver with a touchscreen display (optional display device)
- New sensor membrane that enables acetaminophen use without any effect on glucose readingsǂ
"It is an exciting time for diabetes management, as new advancements in diabetes monitoring technology allow patients to move away from the traditional fingerstick blood glucose monitoring to continuous blood glucose monitoring" said Dr. Rémi Rabasa-Lhoret, Endocrinologist & Director of the
More information on Dexcom G6 can be found at www.dexcom.com.
About Dexcom G6
The Dexcom G6 is a stand-alone CGM system for people with diabetes who use insulin – who administer insulin either with multiple daily injections or an insulin pump. With the Dexcom G6, the sensor is worn separately from an insulin pump and is inserted under the skin to measure the level of glucose in the interstitial fluid (fluid in the tissue). The sensor is disposable and should be changed every 10 days.
CGM devices are considered the most significant breakthrough in diabetes management in the past 40 years1 and
*If your glucose alerts and readings from the G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
†To view a list of compatible devices, visit www.dexcom.com/compatibility
ǂ G6 readings can be used to make diabetes treatment decisions when taking up to a maximum acetaminophen dose of 1,000mg every six hours. Taking a higher dose may affect the G6 readings.
1 Clarke SF and Foster JR. A history of blood glucose meters and their role in self-monitoring of diabetes mellitus. Br J Biomed Sci. 2012;(3)2:83-93.
3 Hyperglycemia (High blood glucose).
4 Hypoglycemia (Low blood glucose).